中文 | English
Return
Total: 217 , 1/22
Show Home Prev Next End page: GO
Author:(Xiao-guo DU)

1.Clinical trial of compound sabal berry tablet in the treatment of patients with bladder discomfort after electrocision of benign prostatic hyperplasia

Yu-Feng DU ; Huang-Hui CHEN ; Qun-Jie TAN ; Xiao-Yong GUO

The Chinese Journal of Clinical Pharmacology 2024;40(18):2670-2674

2.Formulation Optimization of Hydroxyylsafflower Yellow A Nanoparticle Using Box-Behnken Response Surface Method and in Vitro Release Evaluation

Yifei XIAO ; Lixin DU ; Qidong WEI ; Huiling LU ; Zhihua GUO ; Ya LI

Traditional Chinese Drug Research & Clinical Pharmacology 2024;35(1):122-131

3.Expression of optineurin in multiple myeloma and its clinical significance

Ni GUO ; Yachun JIA ; Xiao LIANG ; Yanhua MU ; Ke DU ; Yameng WEI ; Yanni GUO ; Guangyao KONG

Journal of Xi'an Jiaotong University(Medical Sciences) 2024;45(2):244-249

4.Correlation Analysis Between Ultrasound Ossification Ratio and Exercise Intensity in Adolescents

Li ZHANG ; Hanze DU ; Yixuan ZHANG ; Yamei YANG ; Zeqing ZHAO ; Xiaoyuan GUO ; Shi CHEN ; Hui PAN ; Xiao YANG ; Jianchu LI

Medical Journal of Peking Union Medical College Hospital 2024;15(5):1198-1203

5.Study on influencing factors of neurobehavioral development in young children suspected of developmental delays

Xiaoman LI ; Lijuan HUANG ; Xiao WANG ; Zumin LIU ; Runmin GUO ; Xueyan NONG ; Xiujuan HUANG ; Jinyuan ZHU ; Yanting CHEN ; Jinlin DU

Acta Universitatis Medicinalis Anhui 2024;59(7):1244-1250

6.Research advance of Flash-RT in tumor treatment

Yuan WANG ; Lehui DU ; Pei ZHANG ; Qingchao SHANG ; Xingdong GUO ; Jiangyue LU ; Xiao LEI ; Baolin QU

China Medical Equipment 2024;21(1):9-14,20

7.Study on Quality Evaluation of Didang Qigui Decoction by HPLC Fingerprint Combined with Multi-component Content Determination

Yijia GUO ; Du CHENG ; Xiao ZHANG ; Liyan LEI ; Yanni LIANG ; Zheng WANG ; Jingfeng YANG

Chinese Journal of Information on Traditional Chinese Medicine 2024;31(3):132-137

8.Rosmarinic acid ameliorates acute liver injury by activating NRF2 and inhibiting ROS/TXNIP/NLRP3 signal pathway

Jun-fu ZHOU ; Xin-yan DAI ; Hui LI ; Yu-juan WANG ; Li-du SHEN ; DU Xiao-bi A ; Shi-ying ZHANG ; Jia-cheng GUO ; Heng-xiu YAN

Acta Pharmaceutica Sinica 2024;59(6):1664-1673

9.A Multicenter, Randomized, Double-blind, and Placebo-parallel Controlled Trial of Tibetan Medicine Ruyi Zhenbaowan in Treatment of Knee Osteoarthritis

Chunquan SUN ; Yanming XIE ; Jinghua GAO ; Weiheng CHEN ; Lianxin WANG ; Shangquan WANG ; Xiangdong TIAN ; Zujian XU ; Yuxin ZHENG ; Mingwang ZHOU ; Chungen LI ; Zhanwang XU ; Jiayi GUO ; Shuangqing DU ; Qigang CHEN ; Quan JI ; Zhiqiang BAI ; Jing XIAO ; Wanli QI ; Weiyi YANG ; Jingxiao ZHANG

Chinese Journal of Experimental Traditional Medical Formulae 2024;30(24):57-67

10.Therapeutic effects of the NLRP3 inflammasome inhibitor N14 in the treatment of gouty arthritis in mice

Xiao-lin JIANG ; Kai GUO ; Yu-wei HE ; Yi-ming CHEN ; Shan-shan DU ; Yu-qi JIANG ; Zhuo-yue LI ; Chang-gui LI ; Chong QIN

Acta Pharmaceutica Sinica 2024;59(5):1229-1237

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 217 , 1/22 Show Home Prev Next End page: GO